Suppliers and packagers for generic pharmaceutical drug: dextrose; potassium chloride

dextrose; potassium chloride

Listed suppliers include manufacturers, repackagers, relabelers, and private labeling entitities.

Applicant	Tradename	Generic Name	Dosage	NDA	NDA/ANDA	Supplier	Package Code	Package	Marketing Start
Fresenius Kabi Usa	DEXTROSE 5% AND POTASSIUM CHLORIDE 0.075%	dextrose; potassium chloride	INJECTABLE;INJECTION	212346	ANDA	Fresenius Kabi USA, LLC	63323-667-10	10 BAG in 1 CASE (63323-667-10) / 1000 mL in 1 BAG (63323-667-01)	2021-04-23
Fresenius Kabi Usa	DEXTROSE 5% AND POTASSIUM CHLORIDE 0.075%	dextrose; potassium chloride	INJECTABLE;INJECTION	212346	ANDA	Fresenius Kabi USA, LLC	63323-669-10	10 BAG in 1 CASE (63323-669-10) / 1000 mL in 1 BAG (63323-669-01)	2021-04-23
Baxter Hlthcare	DEXTROSE 5% AND POTASSIUM CHLORIDE 0.075% IN PLASTIC CONTAINER	dextrose; potassium chloride	INJECTABLE;INJECTION	017634	NDA	Baxter Healthcare Company	0338-0683-04	1000 mL in 1 BAG (0338-0683-04)	1979-02-01
Fresenius Kabi Usa	DEXTROSE 5% AND POTASSIUM CHLORIDE 0.15%	dextrose; potassium chloride	INJECTABLE;INJECTION	212346	ANDA	Fresenius Kabi USA, LLC	63323-667-10	10 BAG in 1 CASE (63323-667-10) / 1000 mL in 1 BAG (63323-667-01)	2021-04-23
Fresenius Kabi Usa	DEXTROSE 5% AND POTASSIUM CHLORIDE 0.15%	dextrose; potassium chloride	INJECTABLE;INJECTION	212346	ANDA	Fresenius Kabi USA, LLC	63323-669-10	10 BAG in 1 CASE (63323-669-10) / 1000 mL in 1 BAG (63323-669-01)	2021-04-23

Dextrose and Potassium Chloride: Pharmaceutical Supplier Landscape Analysis

Last updated: February 19, 2026

This report analyzes the global supplier landscape for dextrose and potassium chloride, critical excipients in pharmaceutical drug manufacturing. The analysis focuses on key suppliers, their production capacities, geographic distribution, and regulatory compliance, providing insights for supply chain risk assessment and procurement strategy.

Who Are the Leading Global Suppliers of Pharmaceutical-Grade Dextrose?

The pharmaceutical-grade dextrose market is characterized by a concentrated supplier base, with a few major players dominating global production. These suppliers offer dextrose in various forms, including anhydrous and monohydrate, meeting stringent USP, EP, and JP pharmacopeial standards. Key suppliers and their general market presence are detailed below.

• Cargill, Inc.: A significant global producer of agricultural commodities and ingredients, Cargill offers pharmaceutical-grade dextrose. Their production is integrated with corn wet milling operations, allowing for large-scale supply. Cargill's primary manufacturing facilities are located in North America and Europe. The company emphasizes quality control and traceability throughout its supply chain.
• ADM (Archer Daniels Midland Company): ADM is another major player in corn processing, producing a substantial volume of pharmaceutical dextrose. Their global network of manufacturing plants, particularly in the United States and South America, supports consistent supply. ADM's offerings comply with relevant pharmacopeia requirements and are often used in intravenous solutions and other drug formulations.
• Ingredion Incorporated: Ingredion produces a range of starches and sweeteners, including pharmaceutical-grade dextrose. With manufacturing sites across North America, South America, and Asia, Ingredion provides a geographically diverse supply base. Their product portfolio includes dextrose anhydrous and dextrose monohydrate, tailored for pharmaceutical applications.
• Roquette Frères: This French company is a global leader in plant-based ingredients, including dextrose derived from wheat and corn. Roquette operates manufacturing facilities in Europe and North America, ensuring a robust supply for pharmaceutical clients. They offer specialized grades of dextrose for specific drug delivery systems and formulations.
• Südzucker AG: As one of Europe's largest sugar and starch producers, Südzucker provides pharmaceutical-grade dextrose from its beet and corn processing operations. Their European manufacturing base is a key factor in supplying regional pharmaceutical manufacturers. Südzucker's commitment to quality assurance is central to its pharmaceutical ingredient offerings.

Dextrose Supplier Capacity and Geographic Footprint

Supplier	Primary Feedstock	Key Product Forms	Major Manufacturing Regions	Estimated Annual Capacity (Metric Tons)	Notes
Cargill, Inc.	Corn	Dextrose Anhydrous, Dextrose Monohydrate	North America, Europe	> 500,000	Global supply chain, strong R&D in excipients.
ADM	Corn	Dextrose Anhydrous, Dextrose Monohydrate	North America, South America	> 450,000	Integrated agricultural supply chain.
Ingredion	Corn, Wheat	Dextrose Anhydrous, Dextrose Monohydrate	North America, South America, Asia	> 300,000	Diverse product portfolio for pharmaceutical applications.
Roquette Frères	Wheat, Corn	Dextrose Anhydrous, Dextrose Monohydrate	Europe, North America	> 250,000	Specializes in plant-based ingredients, focus on innovation.
Südzucker AG	Sugar Beet, Corn	Dextrose Anhydrous, Dextrose Monohydrate	Europe	> 200,000	Strong European market presence.

Note: Capacity figures are estimated and based on publicly available information regarding global corn/starch processing volumes, not specific dextrose production lines. Actual pharmaceutical-grade dextrose capacity may be a subset of total production.

What Are the Key Considerations for Sourcing Pharmaceutical-Grade Potassium Chloride?

The supply of pharmaceutical-grade potassium chloride (KCl) is also dominated by a number of global producers. These suppliers must adhere to stringent purity standards, as potassium chloride is commonly used in injectable solutions, electrolyte replacements, and as a critical component in parenteral nutrition.

Leading Pharmaceutical-Grade Potassium Chloride Suppliers

• SQM (Sociedad Química y Minera de Chile S.A.): A major global producer of specialty chemicals, SQM is one of the largest suppliers of potassium chloride. Their production is primarily from the Atacama Desert in Chile, a rich source of natural salts. SQM's high-purity grades meet rigorous pharmaceutical requirements.
• Compass Minerals International, Inc.: This company mines and processes salt and other mineral products. Compass Minerals offers a pharmaceutical-grade potassium chloride product line, with production facilities in North America. They focus on reliable supply and consistent quality for critical applications.
• Uralkali (PJSC Uralkali): One of the world's largest potash producers, Uralkali is based in Russia. While historically serving agricultural markets, they also produce high-purity potassium chloride suitable for pharmaceutical use, meeting international pharmacopeial standards.
• JSC Belaruskali: Another major Russian potash producer, Belaruskali is a significant global supplier of potash. They provide pharmaceutical-grade potassium chloride, complying with USP and EP monographs, from their extensive mining operations in Belarus.
• China National Salt Industry Corporation (China Salt): As the primary state-owned salt producer in China, China Salt is a substantial supplier of various salt products, including pharmaceutical-grade potassium chloride. Their large-scale operations and extensive distribution network serve both domestic and international markets.

Potassium Chloride Supplier Specifications and Regulatory Compliance

Pharmaceutical-grade potassium chloride must meet specific purity criteria to be suitable for drug manufacturing. Key specifications include:

• Assay: Typically 99.0% to 100.5% KCl on a dried basis, as per USP <841> and EP 2.4.8.
• Impurities: Strict limits on heavy metals (e.g., lead, arsenic), sodium, sulfate, and other trace elements.
• pH: Typically between 5.0 and 8.0 for a 5% solution.
• Loss on Drying: Limits on moisture content, critical for anhydrous forms.
• Identification Tests: Confirmation of potassium and chloride ions through specific chemical reactions.

Suppliers are generally required to have:

• Good Manufacturing Practices (GMP) Certification: Essential for pharmaceutical ingredient manufacturers.
• Drug Master Files (DMFs): Filed with regulatory agencies like the U.S. Food and Drug Administration (FDA) or European Medicines Agency (EMA) to provide confidential detailed information about manufacturing, processing, packaging, and storing the drug substance.
• Certificates of Analysis (CoAs): Accompanying each batch, verifying compliance with specified standards.
• Traceability: Robust systems for tracking raw materials to finished product.

What Are the Primary Applications of Dextrose and Potassium Chloride in Pharmaceuticals?

Dextrose and potassium chloride are fundamental components in numerous pharmaceutical formulations due to their physiological compatibility and functional properties.

Dextrose Applications

Dextrose, a simple sugar, is primarily used for its caloric value and its role as a carbohydrate source.

• Intravenous Solutions: Dextrose solutions (e.g., D5W, D10W) are widely used as a source of hydration, calories, and energy for patients unable to consume food orally. They also serve as diluents for other injectable medications.
• Parenteral Nutrition: Dextrose is a primary carbohydrate component in total parenteral nutrition (TPN) formulations, providing essential energy for patients requiring long-term nutritional support.
• Excipient in Oral Formulations: Dextrose can act as a binder, filler, or sweetening agent in solid oral dosage forms like tablets and capsules.
• Cell Culture Media: In biopharmaceutical manufacturing, dextrose is a critical nutrient source for cell growth in bioreactors.
• Lyophilization (Freeze-Drying): Dextrose can be used as a cryoprotectant or lyoprotectant to stabilize sensitive biological products during freeze-drying.

Potassium Chloride Applications

Potassium chloride is an essential electrolyte, vital for maintaining cellular function and fluid balance.

• Electrolyte Replacement Therapy: Administered intravenously or orally to treat hypokalemia (low potassium levels), often associated with diuretic use, vomiting, or diarrhea.
• Parenteral Nutrition: An essential component of TPN to maintain normal potassium homeostasis.
• Dialysis Solutions: Used in hemodialysis and peritoneal dialysis to control electrolyte concentrations in dialysate.
• Buffer Systems: Potassium chloride can contribute to the buffering capacity of certain pharmaceutical solutions.
• Contrast Media: In some imaging applications, potassium chloride is used in the formulation of contrast agents.

What Are the Supply Chain Risks Associated with These Excipients?

While generally considered stable commodities, the supply of pharmaceutical-grade dextrose and potassium chloride is subject to several risks that can impact availability and cost.

Supply Chain Risk Factors

• Geopolitical Instability: Major production regions for both dextrose (e.g., corn-belt regions in North America) and potassium chloride (e.g., Russia, Belarus, Chile) can be subject to geopolitical tensions, trade disputes, or sanctions, disrupting supply routes or impacting export capabilities.
• Raw Material Availability and Price Volatility:
  • Dextrose: Dependence on agricultural commodities like corn makes dextrose prices susceptible to weather events (droughts, floods), crop diseases, and global demand shifts for corn as a food, feed, or biofuel.
  • Potassium Chloride: While geological reserves are extensive, mining operations can be affected by labor disputes, regulatory changes, or environmental concerns.
• Logistics and Transportation: Global shipping disruptions, port congestion, fuel price fluctuations, and container shortages can significantly increase lead times and costs.
• Quality and Regulatory Compliance: Any lapse in GMP standards or failure to meet pharmacopeial specifications by a supplier can lead to batch rejections, recalls, and severe supply chain interruptions. Maintaining DMF integrity and undergoing regular audits is critical.
• Natural Disasters and Climate Change: Extreme weather events can impact agricultural yields for dextrose feedstocks or disrupt mining and processing operations for potassium chloride.
• Concentrated Supplier Base: For certain grades or regions, the supplier base can be relatively concentrated, increasing vulnerability if a key supplier experiences production issues.
• Increased Demand: Surges in demand, for example, during public health crises requiring large volumes of intravenous fluids, can strain existing production capacities.

What Are the Regulatory Requirements for Pharmaceutical-Grade Dextrose and Potassium Chloride?

Compliance with pharmacopeial standards and regulatory guidelines is paramount for pharmaceutical excipients.

Key Regulatory Frameworks and Standards

• Pharmacopeias:
  • United States Pharmacopeia (USP): Monographs for Dextrose (Monograph No. 1602) and Potassium Chloride (Monograph No. 0751) define the quality, purity, and testing requirements.
  • European Pharmacopoeia (EP): Similar monographs exist for Dextrose (monograph 0742 for anhydrous, 0103 for monohydrate) and Potassium Chloride (monograph 0723).
  • Japanese Pharmacopoeia (JP): Provides equivalent standards for these excipients.
• Good Manufacturing Practices (GMP): Manufacturers must adhere to cGMP guidelines (e.g., FDA 21 CFR Part 210/211, ICH Q7) to ensure consistent quality and safety. This includes stringent controls over facilities, equipment, personnel, documentation, and quality control testing.
• Drug Master Files (DMFs): As mentioned, DMFs are critical for regulatory submissions. They allow suppliers to provide confidential manufacturing details directly to regulatory agencies without disclosing proprietary information to drug product manufacturers.
• International Council for Harmonisation (ICH) Guidelines: ICH Q7 (GMP for Active Pharmaceutical Ingredients) is also highly relevant for the production of pharmaceutical excipients. ICH Q3D addresses elemental impurities, which are crucial for both dextrose and potassium chloride.
• Food and Drug Administration (FDA): The FDA oversees the safety and efficacy of drug products, including the excipients used. Suppliers are subject to FDA inspections.
• European Medicines Agency (EMA): The EMA plays a similar role in the European Union, with specific guidelines and requirements for excipients.

Key Takeaways

The supply of pharmaceutical-grade dextrose and potassium chloride is managed by a global network of large agricultural commodity processors and mineral extraction companies. Key suppliers like Cargill, ADM, Ingredion, Roquette Frères, and Südzucker dominate the dextrose market, leveraging integrated feedstock operations. For potassium chloride, major players include SQM, Compass Minerals, Uralkali, Belaruskali, and China Salt, benefiting from extensive mineral reserves.

Both excipients are critical for parenteral solutions, nutritionals, and various other drug formulations, demanding adherence to stringent USP, EP, and JP pharmacopeial standards. Regulatory compliance, including GMP certification and the maintenance of Drug Master Files, is non-negotiable.

Supply chain risks are multifaceted, encompassing geopolitical instability, raw material price volatility, agricultural yield dependency (for dextrose), mining operational factors (for potassium chloride), logistics disruptions, and potential quality control failures. Understanding these risks is crucial for pharmaceutical manufacturers to ensure a robust and uninterrupted supply of these essential ingredients.

Frequently Asked Questions

1. What is the typical shelf life for pharmaceutical-grade dextrose and potassium chloride? Pharmaceutical-grade dextrose typically has a shelf life of 2 to 5 years when stored under recommended conditions (cool, dry, protected from light). Pharmaceutical-grade potassium chloride generally has a very long shelf life, often exceeding 5 years, due to its chemical stability. Specific shelf lives are determined by the manufacturer and confirmed by stability testing.

2. Are there alternative excipients that can replace dextrose in intravenous solutions? For caloric and energy provision in intravenous solutions, other carbohydrates like fructose or sorbitol can be used, but dextrose is the most common due to its physiological compatibility and metabolic pathway. In specific applications, other energy sources like lipids may be used in conjunction with or as alternatives to carbohydrate infusions in TPN.

3. How do regulatory bodies ensure the quality of imported pharmaceutical excipients? Regulatory bodies like the FDA and EMA ensure quality through various mechanisms, including the review of Drug Master Files (DMFs), risk-based inspections of foreign manufacturing facilities, import alerts for non-compliant products, and analysis of imported samples at designated laboratories. Companies importing excipients are responsible for ensuring their suppliers meet all applicable regulatory requirements.

4. What are the implications of elemental impurities on the choice of dextrose and potassium chloride suppliers? ICH Q3D guidelines mandate the control of elemental impurities. Suppliers must demonstrate that their manufacturing processes effectively minimize or control potential elemental contaminants (e.g., lead, arsenic, cadmium). Manufacturers must select suppliers with robust quality systems and testing protocols that meet these stringent requirements to ensure the safety of their final drug products.

5. Can fluctuations in the price of corn directly impact the cost of pharmaceutical dextrose? Yes, significant fluctuations in the price of corn, driven by agricultural yields, global demand, and biofuel mandates, can directly influence the cost of producing pharmaceutical-grade dextrose. This is because corn is the primary feedstock for most large-scale dextrose manufacturers, and the cost of raw materials is a significant component of the final product price.

Citations

[1] United States Pharmacopeia. (n.d.). USP-NF Online. Retrieved from uspnf.com [2] European Directorate for the Quality of Medicines & HealthCare. (n.d.). Ph. Eur. Online. Retrieved from www.edqm.eu [3] Archer Daniels Midland Company. (2023). Annual Report. [4] Cargill, Inc. (2023). Sustainability Report. [5] Compass Minerals International, Inc. (2023). Annual Report. [6] Ingredion Incorporated. (2023). Annual Report. [7] International Council for Harmonisation of Technical Requirements for Pharmaceuticals for Human Use. (1999). ICH Harmonised Tripartite Guideline Q7: Good Manufacturing Practice Guide for Active Pharmaceutical Ingredients. [8] International Council for Harmonisation of Technical Requirements for Pharmaceuticals for Human Use. (2015). ICH Harmonised Guideline Q3D: Guideline for Elemental Impurities. [9] Roquette Frères. (2023). Product Portfolio. [10] Sociedad Química y Minera de Chile S.A. (SQM). (2023). Annual Report. [11] Südzucker AG. (2023). Annual Report. [12] Uralkali (PJSC Uralkali). (2023). Annual Report.